Online citations, reference lists, and bibliographies.
← Back to Search

Common Variation In The Lipoprotein Lipase Gene: Effects On Plasma Lipids And Risk Of Atherosclerosis.

R. Fisher, S. Humphries, P. Talmud
Published 1997 · Medicine, Biology

Cite This
Download PDF
Analyze on Scholarcy
Share
The importance of the enzyme lipoprotein lipase (LPL) in the development of dyslipidaemia and atherosclerosis is increasingly recognised. Variations in the LPL gene which are common in the general population have been shown to be associated with alterations in plasma lipids. D9N and N291S both occur at carrier frequencies of up to about 5% and have been associated with increased plasma triacylglycerol and decreased high density lipoprotein cholesterol concentrations, effects which seem to be magnified in more obese individuals. S447X carrier frequency is approximately 20%, but unlike carriers of N9 or S291, X447 carriers appear to have a more favourable lipid profile. A transition within the LPL promoter at position-93 may lead to increased LPL activity and have a beneficial effect on plasma lipids. Greater knowledge of the underlying mechanisms of these variations within the LPL gene may be of considerable importance in understanding genetic predisposition to atherosclerosis and heart disease.
This paper references
10.1161/01.ATV.12.10.1176
Familial combined hyperlipidemia and abnormal lipoprotein lipase.
S. P. Babirak (1992)
Two DNA polymorphisms in the lipoprotein lipase gene and their associations with factors related to cardiovascular disease.
Y. I. Ahn (1993)
10.1038/ng0595-6
The low down on lipoprotein lipase
H. Funke (1995)
10.1161/01.ATV.15.10.1695
Patients with apoE3 deficiency (E2/2, E3/2, and E4/2) who manifest with hyperlipidemia have increased frequency of an Asn 291-->Ser mutation in the human LPL gene.
H. Zhang (1995)
Mutational analysis of human lipoprotein lipase by carboxy-terminal truncation.
K. Kozaki (1993)
10.1002/GEPI.1370100304
Association of a Pvull RFLP at the lipoprotein lipase locus with fasting insulin levels in Hispanic men
S. Cole (1993)
10.1111/j.1399-0004.1995.tb04112.x
Common genetic variants of lipoprotein lipase that relate to lipid transport in patients with premature coronary artery disease
Q. Zhang (1995)
10.1161/01.ATV.10.4.520
Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia.
M. Austin (1990)
10.1161/01.ATV.15.4.468
A common variant in the gene for lipoprotein lipase (Asp9→Asn) : functional implications and prevalence in normal and hyperlipidemic subjects
Y. Tugrul (1995)
10.1161/01.CIR.96.3.733
Lipoprotein lipase variants D9N and N291S are associated with increased plasma triglyceride and lower high-density lipoprotein cholesterol concentrations: studies in the fasting and postprandial states: the European Atherosclerosis Research Studies.
C. Gerdes (1997)
10.1016/0021-9150(94)93262-X
A common variant in the gene for lipoprotein lipase (Asp9-->Asn). Functional implications and prevalence in normal and hyperlipidemic subjects.
F. Mailly (1995)
10.1161/01.ATV.14.7.1090
DNA variants at the LPL gene locus associate with angiographically defined severity of atherosclerosis and serum lipoprotein levels in a Welsh population.
R. Mattu (1994)
10.1002/HUMU.1380020402
A suggested nomenclature for designating mutations
A. Beaudet (1993)
10.1016/0021-9150(95)05736-6
Association between the LPL-D9N mutation in the lipoprotein lipase gene and plasma lipid traits in myocardial infarction survivors from the ECTIM Study.
F. Mailly (1996)
10.1093/NAR/17.21.8899
A BglII RFLP at the lipoprotein lipase gene.
R. Hegele (1989)
Missense mutations in exon 5 of the human lipoprotein lipase gene. Inactivation correlates with loss of dimerization.
A. Hata (1992)
10.1016/0005-2728(92)90119-M
Is bicarbonate in Photosystem II the equivalent of the glutamate ligand to the iron atom in bacterial reaction centers?
X. Wang (1992)
10.1007/BF00184584
Lipoprotein lipase activity in patients with combined hyperlipidaemia
M. Seed (2004)
Prevalence of alleles encoding defective lipoprotein lipase in hypertriglyceridemic patients of French Canadian descent.
A. Minnich (1995)
10.1161/01.CIR.94.8.1913
The Asp9 Asn mutation in the lipoprotein lipase gene is associated with increased progression of coronary atherosclerosis. REGRESS Study Group, Interuniversity Cardiology Institute, Utrecht, The Netherlands. Regression Growth Evaluation Statin Study.
J. Jukema (1996)
10.1021/BI00436A001
Structure of the human lipoprotein lipase gene.
S. Deeb (1989)
10.1093/NAR/15.18.7657
Two polymorphisms in the human lipoprotein lipase (LPL) gene.
K. Fisher (1987)
10.1161/01.ATV.15.4.543
The 13th annual meeting of the European Lipoprotein Club.
L. Aggerbeck (1991)
10.1016/S0021-9150(97)87500-4
76 Lipoprotein lipase −93T/G transition is associated with lower plasma triglyceride levels and increased promoter activity in vitro
P. Talmud (1996)
10.1093/NAR/17.23.10146
Two RFLPs at the lipoprotein lipase (LPL) gene.
R. Hegele (1989)
10.1111/j.1365-2362.1989.tb00254.x
Lipoprotein lipase with a defect in lipid interface recognition in a case with type I hyperlipidaemia
J. Kobayashi (1989)
A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) results in altered postprandial chylomicron triglyceride and retinyl palmitate response in normolipidemic carriers.
S. Pimstone (1996)
10.1016/0021-9150(95)05641-6
The lipoprotein lipase (Asn291-->Ser) mutation is associated with elevated lipid levels in families with familial combined hyperlipidaemia.
M. J. Hoffer (1996)
Catalytic triad residue mutation (Asp156----Gly) causing familial lipoprotein lipase deficiency. Co-inheritance with a nonsense mutation (Ser447----Ter) in a Turkish family.
F. Faustinella (1991)
10.1161/01.ATV.17.10.1969
A common mutation in the lipoprotein lipase gene promoter, -93T/G, is associated with lower plasma triglyceride levels and increased promoter activity in vitro.
S. Hall (1997)
Structural and functional roles of highly conserved serines in human lipoprotein lipase. Evidence that serine 132 is essential for enzyme catalysis.
F. Faustinella (1991)
10.2337/diab.41.11.1385
Features of Insulin-Resistance Syndrome in Men From French Caribbean Islands: The Telecom Study
A. Fontbonne (1992)
10.1002/(SICI)1098-1004(1997)10:6<465::AID-HUMU8>3.0.CO;2-C
Familial lipoprotein lipase (LPL) deficiency: A catalogue of LPL gene mutations identified in 20 patients from the UK, Sweden, and Italy
F. Mailly (1997)
Structural features in lipoprotein lipase necessary for the mediation of lipoprotein uptake into cells.
A. Krapp (1995)
10.1001/JAMA.1991.03460070086049
The familial hyperchylomicronemia syndrome. New insights into underlying genetic defects.
S. Santamarina-Fojo (1991)
Homozygosity for two point mutations in the lipoprotein lipase (LPL) gene in a patient with familial LPL deficiency: LPL(Asp9-->Asn, Tyr262-->His).
M. Rouis (1996)
10.1038/NG0595-28
A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis
P. Reymer (1995)
High frequency of mutations in the human lipoprotein lipase gene in pregnancy-induced chylomicronemia: possible association with apolipoprotein E2 isoform.
Y. Ma (1994)
10.1016/0005-2760(92)90165-R
Structure and functional properties of lipoprotein lipase.
C. Wang (1992)
10.1111/j.1365-2362.1996.tb02146.x
Lipoprotein lipase gene mutations D9N and N291S in four pedigrees with familial combined hyperlipidaemia
T. W. A. D. Bruin (1996)
10.1172/JCI119323
A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk of ischemic heart disease.
H. Wittrup (1997)
10.1007/BF00201544
DNA polymorphism haplotypes of the human lipoprotein lipase gene: possible association with high density lipoprotein levels
C. Heizmann (2004)
10.1161/01.ATV.17.3.595
Ser447stop mutation in lipoprotein lipase is associated with elevated HDL cholesterol levels in normolipidemic males.
J. Kuivenhoven (1997)
Interaction of the lipoprotein lipase asparagine 291-->serine mutation with body mass index determines elevated plasma triacylglycerol concentrations: a study in hyperlipidemic subjects, myocardial infarction survivors, and healthy adults.
R. Fisher (1995)
10.1016/0378-1119(87)90023-0
Molecular cloning and sequence analysis of cDNA encoding lipoprotein lipase of guinea pig.
S. Enerbäck (1987)
10.1016/0888-7543(87)90005-X
Human genes involved in lipolysis of plasma lipoproteins: mapping of loci for lipoprotein lipase to 8p22 and hepatic lipase to 15q21.
R. Sparkes (1987)
10.1128/MCB.12.10.4622
Characterization of the human lipoprotein lipase (LPL) promoter: evidence of two cis-regulatory regions, LP-alpha and LP-beta, of importance for the differentiation-linked induction of the LPL gene during adipogenesis.
S. Enerbäck (1992)
10.1016/0005-2760(96)00059-8
Common sequence variants of lipoprotein lipase: standardized studies of in vitro expression and catalytic function.
H. Zhang (1996)
Structure of bovine milk lipoprotein lipase.
C. Y. Yang (1989)
10.1111/J.1432-1033.1982.TB06640.X
Molecular properties of lipoprotein lipase. Effects of limited trypsin digestion on molecular weight and secondary structure.
T. Olivecrona (1982)
10.1073/PNAS.92.10.4462
A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipidemia and low LPL activity.
W. Yang (1995)
Regulatory mutations in the human lipoprotein lipase gene in patients with familial combined hyperlipidemia and coronary artery disease.
W. Yang (1996)
10.1093/NAR/16.6.2741
Bst NI (Eco RII) RFLP in the lipoprotein lipase gene (LPL).
H. Funke (1988)
Lipoprotein lipase genotypes for a common premature termination codon mutation detected by PCR-mediated site-directed mutagenesis and restriction digestion.
J. Stocks (1992)
10.1074/JBC.271.36.21906
Structure-Function Relationship of Lipoprotein Lipase-mediated Enhancement of Very Low Density Lipoprotein Binding and Catabolism by the Low Density Lipoprotein Receptor
S. Salinelli (1996)
10.1161/01.ATV.14.8.1250
Analysis of DNA changes in the LPL gene in patients with familial combined hyperlipidemia.
É. Gagné (1994)
10.1016/S0006-291X(05)80113-5
A heterozygous mutation (the codon for Ser447----a stop codon) in lipoprotein lipase contributes to a defect in lipid interface recognition in a case with type I hyperlipidemia.
J. Kobayashi (1992)
10.1161/01.ATV.14.2.193
Factor VII coagulant activity and antigen levels in healthy men are determined by interaction between factor VII genotype and plasma triglyceride concentration.
S. Humphries (1994)
10.1073/PNAS.77.1.604
Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins].
A. Sniderman (1980)
10.1161/01.ATV.11.5.1192
Lipoprotein lipase activity in skeletal muscle is related to insulin sensitivity.
T. Pollare (1991)
Combined effects of lipoprotein lipase and apolipoprotein E polymorphisms on lipid and lipoprotein levels in the Stanislas cohort.
D. Salah (1997)
10.1016/0021-9150(92)90130-9
Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden.
R. E. Peacock (1992)
10.1016/0021-9150(89)90037-3
DNA polymorphisms at the lipoprotein lipase gene: associations in normal and hypertriglyceridaemic subjects.
J. Chamberlain (1989)
10.1056/NEJM199106203242502
A mutation in the human lipoprotein lipase gene as the most common cause of familial chylomicronemia in French Canadians.
Y. Ma (1991)
10.1172/JCI116222
Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities.
G. Miesenböck (1993)
Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. Etude Cas Témoin sur l'Infarctus du Myocarde.
R. Jemaa (1995)
Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome
J. Brunzell (1989)
10.1136/bmj.303.6804.704
Importance of obesity.
J. Garrow (1991)
10.1097/00041433-199206000-00005
Genetic dyslipoproteinemias: role of lipoprotein lipase and apolipoprotein C-ll
S. Santamarina-Fojo (1992)
10.1093/NAR/15.16.6763
RFLP for the human lipoprotein lipase (LPL) gene: HindIII.
C. Heinzmann (1987)
10.1042/CS0500249
Post-heparin plasma lipoprotein lipase and hepatic lipase in normal subjects and in patients with hypertriglyceridaemia: correlations to sex, age and various parameters of triglyceride metabolism.
J. Huttunen (1976)
10.1161/01.ATV.13.7.1110
Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia.
S. Venkatesan (1993)
10.1093/NAR/18.18.5407
Direct detection and automated sequencing of individual alleles after electrophoretic strand separation: identification of a common nonsense mutation in exon 9 of the human lipoprotein lipase gene.
A. Hata (1990)
10.1161/01.ATV.14.6.869
The LPL gene in individuals with familial combined hyperlipidemia and decreased LPL activity.
D. Nevin (1994)
10.1210/JCEM.79.5.7962342
Molecular screening of the lipoprotein lipase gene in hypertriglyceridemic members of familial noninsulin-dependent diabetes mellitus families.
S. Elbein (1994)
10.1093/HMG/4.9.1543
A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemia.
P. Reymer (1995)
10.1093/NAR/16.24.11856
Bst-1 RFLP at the human lipoprotein lipase (LPL) gene locus.
S. Li (1988)
10.1038/343771A0
Structure of human pancreatic lipase
F. Winkler (1990)
A novel missense mutation in the C-terminal domain of lipoprotein lipase (Glu410-->Val) leads to enzyme inactivation and familial chylomicronemia.
L. Previato (1994)
10.1161/01.ATV.11.2.298
Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects.
J. de Graaf (1991)
10.1016/0026-0495(94)90258-5
Lipoprotein Lipase Activity and Plasma Triglyceride Clearance Are Elevated in Endurance-Trained Women
T. R. Podl (1994)
10.1016/0014-5793(95)00582-T
The mutant Asn291 → Ser human lipoprotein lipase is associated with reduced catalytic activity and does not influence binding to heparin
R. Buscà (1995)
Heterozygosity for Asn291-->Ser mutation in the lipoprotein lipase gene in two Finnish pedigrees: effect of hyperinsulinemia on the expression of hypertriglyceridemia.
M. Syvänne (1996)
10.1016/0002-8703(86)90296-6
The triglyceride issue: a view from Framingham.
W. Castelli (1986)
10.1097/00041433-199304000-00009
Genetics and molecular biology of familial combined hyperlipidemia
P. Kwiterovich (1993)



This paper is referenced by
10.1093/aje/kwn235
Seven lipoprotein lipase gene polymorphisms, lipid fractions, and coronary disease: a HuGE association review and meta-analysis.
G. S. Sagoo (2008)
10.1016/S0531-5131(02)01275-X
APOA5—a recent addition to genes determining plasma triglycerides
P. J. Talmud (2003)
10.1186/s12944-017-0419-4
Common variants in the genes of triglyceride and HDL-C metabolism lack association with coronary artery disease in the Pakistani subjects
S. U. Shahid (2017)
10.1016/j.pcad.2016.08.003
Triglyceride Treatment in the Age of Cholesterol Reduction.
N. Agrawal (2016)
Metabolic and genetic determinants of HDL in families with low HDL cholesterol and premature coronary heart disease
A. Soro-Paavonen (2004)
10.1053/BEAN.2001.0150
Atherosclerosis and the genetic basis of lipoprotein disease
A. Rother (2001)
10.1007/s00431-010-1355-8
Lipoprotein lipase gene polymorphisms and risks of childhood obesity in Chinese preschool children
L. Wang (2010)
10.1016/j.bbagrm.2017.01.007
Regulation of the human lipoprotein lipase gene by the forkhead box transcription factor FOXA2/HNF-3β in hepatic cells.
M. Kanaki (2017)
10.1017/S0003480002001057
Genetic and environmental determinants of plasma high density lipoprotein cholesterol and apolipoprotein AI concentrations in healthy middle-aged men.
P. Talmud (2002)
10.1016/J.ARTERI.2011.02.002
Análisis de la influencia de polimorfismos en APOE, APOA5, LPL, LIPC y CETP sobre los niveles de triglicéridos en población laboral malagueña
María José Ariza (2011)
Akademia Medyczna w Gdańsku Zakład Immunologii, Katedra Histologii i Immunologii Akademii Medycznej w Gdańsku
Joanna Lidia (2006)
10.1042/CS20060344
The lipoprotein lipase gene serine 447 stop variant influences hypertension-induced left ventricular hypertrophy and risk of coronary heart disease.
P. Talmud (2007)
Review article Genetic polymorphisms: importance for response to HMG-CoA reductase inhibitors
A. H. M. D. Zee (2002)
10.1097/01.HJH.0000125456.28861.E4
The S447X polymorphism of the lipoprotein lipase gene is associated with lipoprotein lipid and blood pressure levels in Chinese patients with essential hypertension
Aiping Liu (2004)
Titre du mémoire CONTRIBUTION DE LA DÉFICIENCE EN LIPOPROTÉINE LIPASE (LPL) AU PROFIL CARDIOMÉTABOLIQUE LIÉ À L'ADIPONECTINE CHEZ LES FEMMES
Yacine Loucif (2011)
10.1034/J.1399-0004.1999.560406.X
Association of pre-eclampsia with common coding sequence variations in the lipoprotein lipase gene.
C. Hubel (1999)
10.1038/sj.ijo.0803332
Lipoprotein lipase gene S447X polymorphism modulates the relation between central obesity and serum lipids, a twin study
A. Huang (2006)
10.3389/fgene.2012.00089
Population-Based Resequencing of LIPG and ZNF202 Genes in Subjects with Extreme HDL Levels
Hamid Razzaghi (2012)
10.1016/S0021-9150(01)00725-0
Genetic polymorphisms: importance for response to HMG-CoA reductase inhibitors.
A. H. Maitland-van der Zee (2002)
10.1152/JAPPL.2001.91.3.1334
Evidence of LPL gene-exercise interaction for body fat and LPL activity: the HERITAGE Family Study.
C. Garenc (2001)
10.1016/j.nut.2015.05.001
Association of the leptin receptor Gln223 Arg polymorphism with lipid profile in obese Pakistani subjects.
N. Shabana (2015)
10.1093/QJMED/92.4.223
Genetic markers to predict polygenic disease: a new problem for social genetics.
D. Galton (1999)
10.1002/HUMU.9054
Genotype‐phenotype studies of six novel LPL mutations in Chinese patients with hypertriglyceridemia
L. Y. Chan (2002)
10.1159/000075993
Genetics and Gene Manipulation Therapy of Premature Coronary Artery Disease
R. Chaer (2004)
10.1016/S0021-9150(00)00717-6
Lipoprotein lipase D9N, N291S and S447X polymorphisms: their influence on premature coronary heart disease and plasma lipids.
F. V. van Bockxmeer (2001)
10.1093/humupd/dms060
Genetic variants in pre-eclampsia: a meta-analysis.
A. Buurma (2013)
10.1007/S11373-005-7707-0
Lipoprotein lipase gene is linked and associated with hypertension in Taiwan young-onset hypertension genetic study.
Pei Chen (2005)
10.1016/S0021-9150(99)80339-6
Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis.
H. Wittrup (1999)
10.1007/0-387-23329-6_6
The Role of Bioinformatics in Genomic Medicine
A. V. Kampen (2006)
10.1002/bab.1500
Orlistat response to missense mutations in lipoprotein lipase
Huayou Chen (2017)
10.1542/PEDS.108.3.E50
Age-related effects of genetic variation on lipid levels: The Columbia University BioMarkers Study.
P. Talmud (2001)
10.1007/S11883-999-0052-4
Common mutations of the lipoprotein lipase gene and their clinical significance
S. Gehrisch (1999)
See more
Semantic Scholar Logo Some data provided by SemanticScholar